Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector

被引：26

作者：

Bisson, Gregory P. ^{[1
]}

Frank, Ian

Gross, Robert

Lo Re, Vincent, III

Strom, Jordan B.

Wang, Xingmei

Mogorosi, Mpho

Gaolathe, Tendani

Ndwapi, Ndwapi

Friedman, Harvey

Strom, Brian L.

Dickinson, Diana

机构：

[1] Univ Penn, Div Infect Dis, Ctr Clin Epidemiol & Biostat, Sch Med, Philadelphia, PA 19104 USA

[2] Yale Univ, New Haven, CT USA

[3] Princess Marina Hosp, Infect Clin Dis Ctr, Gaborone, Botswana

[4] Independence Surg, Gaborone, Botswana

来源：

AIDS | 2006年 / 20卷 / 09期

关键词：

D O I：

10.1097/01.aids.0000232245.36039.2b

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A large number of HIV-infected patients in sub-Saharan Africa pay out-of-pocket for HAART. This analysis from Botswana indicates that higher median out-of-pocket regimen costs to patients for the initial 30 days of HAART are associated with failure to achieve a viral load < 400 copies/ml [US$32; interquartile range (IQR), 20-84 compared with US$22; (IQR, 17-36), P = 0.001]. HAART costs should be minimized as scale-up efforts in sub-Saharan Africa progress.

引用

页码：1333 / 1336

页数：4

共 16 条

[1] Primary care guidelines for the management of persons infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America [J].